vs

Side-by-side financial comparison of Mueller Water Products, Inc. (MWA) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $318.2M, roughly 2.0× Mueller Water Products, Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 13.6%, a 20.9% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 4.6%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -5.1%).

Mueller Water Products, Inc. (MWP) is a publicly traded company headquartered in Atlanta, Georgia. It is one of the largest manufacturers and distributors of fire hydrants, gate valves, and other water infrastructure products in North America. MWP is made up of two business units—Mueller Co. and Mueller Technologies—that oversee more than a dozen brands and affiliates, including Echologics and Mueller Systems.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

MWA vs RPRX — Head-to-Head

Bigger by revenue
RPRX
RPRX
2.0× larger
RPRX
$622.0M
$318.2M
MWA
Growing faster (revenue YoY)
RPRX
RPRX
+0.2% gap
RPRX
4.8%
4.6%
MWA
Higher net margin
RPRX
RPRX
20.9% more per $
RPRX
34.4%
13.6%
MWA
Faster 2-yr revenue CAGR
RPRX
RPRX
Annualised
RPRX
4.6%
-5.1%
MWA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MWA
MWA
RPRX
RPRX
Revenue
$318.2M
$622.0M
Net Profit
$43.2M
$214.2M
Gross Margin
37.6%
Operating Margin
17.8%
62.4%
Net Margin
13.6%
34.4%
Revenue YoY
4.6%
4.8%
Net Profit YoY
22.4%
2.9%
EPS (diluted)
$0.27
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MWA
MWA
RPRX
RPRX
Q4 25
$318.2M
$622.0M
Q3 25
$380.8M
$609.3M
Q2 25
$380.3M
$578.7M
Q1 25
$364.3M
$568.2M
Q4 24
$304.3M
$593.6M
Q3 24
$348.2M
$564.7M
Q2 24
$356.7M
$537.3M
Q1 24
$353.4M
$568.0M
Net Profit
MWA
MWA
RPRX
RPRX
Q4 25
$43.2M
$214.2M
Q3 25
$52.6M
$288.2M
Q2 25
$52.5M
$30.2M
Q1 25
$51.3M
$238.3M
Q4 24
$35.3M
$208.2M
Q3 24
$10.0M
$544.0M
Q2 24
$47.3M
$102.0M
Q1 24
$44.3M
$4.8M
Gross Margin
MWA
MWA
RPRX
RPRX
Q4 25
37.6%
Q3 25
36.8%
Q2 25
38.3%
Q1 25
35.1%
Q4 24
33.8%
Q3 24
31.8%
Q2 24
36.8%
Q1 24
36.9%
Operating Margin
MWA
MWA
RPRX
RPRX
Q4 25
17.8%
62.4%
Q3 25
18.3%
70.1%
Q2 25
19.4%
36.3%
Q1 25
19.2%
94.0%
Q4 24
15.6%
60.9%
Q3 24
8.2%
Q2 24
18.8%
50.2%
Q1 24
18.0%
-13.0%
Net Margin
MWA
MWA
RPRX
RPRX
Q4 25
13.6%
34.4%
Q3 25
13.8%
47.3%
Q2 25
13.8%
5.2%
Q1 25
14.1%
41.9%
Q4 24
11.6%
35.1%
Q3 24
2.9%
96.3%
Q2 24
13.3%
19.0%
Q1 24
12.5%
0.8%
EPS (diluted)
MWA
MWA
RPRX
RPRX
Q4 25
$0.27
$0.49
Q3 25
$0.34
$0.67
Q2 25
$0.33
$0.07
Q1 25
$0.33
$0.55
Q4 24
$0.22
$0.46
Q3 24
$0.07
$1.21
Q2 24
$0.30
$0.23
Q1 24
$0.28
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MWA
MWA
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$618.7M
Total DebtLower is stronger
$9.0B
Stockholders' EquityBook value
$1.0B
$9.7B
Total Assets
$1.8B
$19.6B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MWA
MWA
RPRX
RPRX
Q4 25
$618.7M
Q3 25
$938.9M
Q2 25
$631.9M
Q1 25
$1.1B
Q4 24
$929.0M
Q3 24
$950.1M
Q2 24
$1.8B
Q1 24
$843.0M
Total Debt
MWA
MWA
RPRX
RPRX
Q4 25
$9.0B
Q3 25
$8.9B
Q2 25
$8.0B
Q1 25
$7.6B
Q4 24
$7.6B
Q3 24
$7.6B
Q2 24
$7.6B
Q1 24
$6.1B
Stockholders' Equity
MWA
MWA
RPRX
RPRX
Q4 25
$1.0B
$9.7B
Q3 25
$981.7M
$9.6B
Q2 25
$929.0M
$9.5B
Q1 25
$873.6M
$9.8B
Q4 24
$834.1M
$10.3B
Q3 24
$810.1M
$10.3B
Q2 24
$791.6M
$9.8B
Q1 24
$754.5M
$9.9B
Total Assets
MWA
MWA
RPRX
RPRX
Q4 25
$1.8B
$19.6B
Q3 25
$1.8B
$19.3B
Q2 25
$1.7B
$18.3B
Q1 25
$1.7B
$17.6B
Q4 24
$1.6B
$18.2B
Q3 24
$1.6B
$18.0B
Q2 24
$1.6B
$17.7B
Q1 24
$1.5B
$16.1B
Debt / Equity
MWA
MWA
RPRX
RPRX
Q4 25
0.92×
Q3 25
0.93×
Q2 25
0.84×
Q1 25
0.78×
Q4 24
0.74×
Q3 24
0.74×
Q2 24
0.78×
Q1 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MWA
MWA
RPRX
RPRX
Operating Cash FlowLast quarter
$61.2M
$827.1M
Free Cash FlowOCF − Capex
$44.0M
FCF MarginFCF / Revenue
13.8%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
1.42×
3.86×
TTM Free Cash FlowTrailing 4 quarters
$173.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MWA
MWA
RPRX
RPRX
Q4 25
$61.2M
$827.1M
Q3 25
$83.5M
$702.6M
Q2 25
$67.4M
$364.0M
Q1 25
$14.3M
$596.1M
Q4 24
$54.1M
$742.5M
Q3 24
$89.3M
$703.6M
Q2 24
$87.3M
$658.2M
Q1 24
$-5.7M
$664.6M
Free Cash Flow
MWA
MWA
RPRX
RPRX
Q4 25
$44.0M
Q3 25
$69.0M
Q2 25
$55.7M
Q1 25
$5.1M
Q4 24
$42.2M
Q3 24
$69.9M
Q2 24
$75.1M
Q1 24
$-15.8M
FCF Margin
MWA
MWA
RPRX
RPRX
Q4 25
13.8%
Q3 25
18.1%
Q2 25
14.6%
Q1 25
1.4%
Q4 24
13.9%
Q3 24
20.1%
Q2 24
21.1%
Q1 24
-4.5%
Capex Intensity
MWA
MWA
RPRX
RPRX
Q4 25
5.4%
Q3 25
3.8%
Q2 25
3.1%
Q1 25
2.5%
Q4 24
3.9%
Q3 24
5.6%
Q2 24
3.4%
Q1 24
2.9%
Cash Conversion
MWA
MWA
RPRX
RPRX
Q4 25
1.42×
3.86×
Q3 25
1.59×
2.44×
Q2 25
1.28×
12.06×
Q1 25
0.28×
2.50×
Q4 24
1.53×
3.57×
Q3 24
8.93×
1.29×
Q2 24
1.85×
6.45×
Q1 24
-0.13×
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MWA
MWA

Water Flow Solutions$173.0M54%
Water Management Solutions$145.2M46%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons